Wockhardt gains on incorporating new subsidiary

05 Jul 2021 Evaluate

Wockhardt is currently trading at Rs. 535.75, up by 2.70 points or 0.51% from its previous closing of Rs. 533.05 on the BSE.

The scrip opened at Rs. 540.00 and has touched a high and low of Rs. 540.50 and Rs. 533.10 respectively. So far 10071 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 804.50 on 26-May-2021 and a 52 week low of Rs. 237.90 on 16-Jul-2020.

Last one week high and low of the scrip stood at Rs. 567.95 and Rs. 515.05 respectively. The current market cap of the company is Rs. 5953.93 crore.

The promoters holding in the company stood at 72.12%, while Institutions and Non-Institutions held 3.19% and 24.69% respectively.

Wockhardt has incorporated a new subsidiary namely Wockhardt Biologics under the provisions of the Companies Act, 2013 on July 2, 2021. The Authorised, subscribed and paid-up capital of the Wockhardt Biologics is Rs 5,00,000 divided into 50,000 equity shares of Rs 10 each out of which Wockhardt will hold approximately 65% of the total share capital while the remaining stake will be held by certain Promoter Group/ Group entities.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1345.90 -17.25 (-1.27%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×